 | • レポートコード：MRC23Q36117 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のインターベンショナル腫瘍アブレーション市場について調査・分析し、世界のインターベンショナル腫瘍アブレーション市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（高周波アブレーション、マイクロ波アブレーション、凍結アブレーション、不可逆エレクトロポレーションアブレーション）、用途別セグメント分析（病院＆診療所、外来手術センター、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Boston Scientific Corporation、Johnson & Johnson、Medtronic Plc、Varian Medical Systems、EDAP TMS S.A.、AngioDynamics、CASCINATION AG、Merit Medical Systems、STARmed、Biomedical Srlなどが含まれています。世界のインターベンショナル腫瘍アブレーション市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、インターベンショナル腫瘍アブレーション市場規模を推定する際に考慮しました。本レポートは、インターベンショナル腫瘍アブレーションの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、インターベンショナル腫瘍アブレーションに関するビジネス上の意思決定に役立てることを目的としています。 ・インターベンショナル腫瘍アブレーション市場の概要 - インターベンショナル腫瘍アブレーションのタイプ別セグメント - 世界のインターベンショナル腫瘍アブレーション市場規模：タイプ別分析（高周波アブレーション、マイクロ波アブレーション、凍結アブレーション、不可逆エレクトロポレーションアブレーション） - インターベンショナル腫瘍アブレーションの用途別セグメント - 世界のインターベンショナル腫瘍アブレーション市場規模：用途別分析（病院＆診療所、外来手術センター、その他） - 世界のインターベンショナル腫瘍アブレーション市場規模予測（2018年-2029年） ・インターベンショナル腫瘍アブレーション市場の成長トレンド - インターベンショナル腫瘍アブレーションの地域別市場規模（2018年-2029年） - インターベンショナル腫瘍アブレーション市場ダイナミクス - インターベンショナル腫瘍アブレーションの業界動向 - インターベンショナル腫瘍アブレーション市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：高周波アブレーション、マイクロ波アブレーション、凍結アブレーション、不可逆エレクトロポレーションアブレーション - 世界のインターベンショナル腫瘍アブレーションのタイプ別市場規模（2018年-2023年） - 世界のインターベンショナル腫瘍アブレーションのタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院＆診療所、外来手術センター、その他 - 世界のインターベンショナル腫瘍アブレーションの用途別市場規模（2018年-2023年） - 世界のインターベンショナル腫瘍アブレーションの用途別市場規模（2024年-2029年） ・インターベンショナル腫瘍アブレーションの地域別市場規模 - 北米のインターベンショナル腫瘍アブレーション市場規模（2018年-2029年） - アメリカのインターベンショナル腫瘍アブレーション市場規模（2018年-2029年） - ヨーロッパのインターベンショナル腫瘍アブレーション市場規模（2018年-2029年） - アジア太平洋のインターベンショナル腫瘍アブレーション市場規模（2018年-2029年） - 中国のインターベンショナル腫瘍アブレーション市場規模（2018年-2029年） - 日本のインターベンショナル腫瘍アブレーション市場規模（2018年-2029年） - 韓国のインターベンショナル腫瘍アブレーション市場規模（2018年-2029年） - インドのインターベンショナル腫瘍アブレーション市場規模（2018年-2029年） - オーストラリアのインターベンショナル腫瘍アブレーション市場規模（2018年-2029年） - 中南米のインターベンショナル腫瘍アブレーション市場規模（2018年-2029年） - 中東・アフリカのインターベンショナル腫瘍アブレーション市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Boston Scientific Corporation、Johnson & Johnson、Medtronic Plc、Varian Medical Systems、EDAP TMS S.A.、AngioDynamics、CASCINATION AG、Merit Medical Systems、STARmed、Biomedical Srl ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Interventional Tumor Ablation market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Interventional Tumor Ablation is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Interventional Tumor Ablation is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Interventional Tumor Ablation in Hospitals And Clinics is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Interventional Tumor Ablation include Boston Scientific Corporation, Johnson & Johnson, Medtronic Plc, Varian Medical Systems, EDAP TMS S.A., AngioDynamics, CASCINATION AG, Merit Medical Systems and STARmed, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Interventional Tumor Ablation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interventional Tumor Ablation.
The Interventional Tumor Ablation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Interventional Tumor Ablation market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Interventional Tumor Ablation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Boston Scientific Corporation
Johnson & Johnson
Medtronic Plc
Varian Medical Systems
EDAP TMS S.A.
AngioDynamics
CASCINATION AG
Merit Medical Systems
STARmed
Biomedical Srl
Segment by Type
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Irreversible Electroporation Ablation
Segment by Application
Hospitals And Clinics
Outpatient Surgery Center
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Interventional Tumor Ablation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Interventional Tumor Ablation Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Radiofrequency Ablation
1.2.3 Microwave Ablation
1.2.4 Cryoablation
1.2.5 Irreversible Electroporation Ablation
1.3 Market by Application
1.3.1 Global Interventional Tumor Ablation Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals And Clinics
1.3.3 Outpatient Surgery Center
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Interventional Tumor Ablation Market Perspective (2018-2029)
2.2 Interventional Tumor Ablation Growth Trends by Region
2.2.1 Global Interventional Tumor Ablation Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Interventional Tumor Ablation Historic Market Size by Region (2018-2023)
2.2.3 Interventional Tumor Ablation Forecasted Market Size by Region (2024-2029)
2.3 Interventional Tumor Ablation Market Dynamics
2.3.1 Interventional Tumor Ablation Industry Trends
2.3.2 Interventional Tumor Ablation Market Drivers
2.3.3 Interventional Tumor Ablation Market Challenges
2.3.4 Interventional Tumor Ablation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Interventional Tumor Ablation Players by Revenue
3.1.1 Global Top Interventional Tumor Ablation Players by Revenue (2018-2023)
3.1.2 Global Interventional Tumor Ablation Revenue Market Share by Players (2018-2023)
3.2 Global Interventional Tumor Ablation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Interventional Tumor Ablation Revenue
3.4 Global Interventional Tumor Ablation Market Concentration Ratio
3.4.1 Global Interventional Tumor Ablation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Interventional Tumor Ablation Revenue in 2022
3.5 Interventional Tumor Ablation Key Players Head office and Area Served
3.6 Key Players Interventional Tumor Ablation Product Solution and Service
3.7 Date of Enter into Interventional Tumor Ablation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Interventional Tumor Ablation Breakdown Data by Type
4.1 Global Interventional Tumor Ablation Historic Market Size by Type (2018-2023)
4.2 Global Interventional Tumor Ablation Forecasted Market Size by Type (2024-2029)
5 Interventional Tumor Ablation Breakdown Data by Application
5.1 Global Interventional Tumor Ablation Historic Market Size by Application (2018-2023)
5.2 Global Interventional Tumor Ablation Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Interventional Tumor Ablation Market Size (2018-2029)
6.2 North America Interventional Tumor Ablation Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Interventional Tumor Ablation Market Size by Country (2018-2023)
6.4 North America Interventional Tumor Ablation Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Interventional Tumor Ablation Market Size (2018-2029)
7.2 Europe Interventional Tumor Ablation Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Interventional Tumor Ablation Market Size by Country (2018-2023)
7.4 Europe Interventional Tumor Ablation Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Interventional Tumor Ablation Market Size (2018-2029)
8.2 Asia-Pacific Interventional Tumor Ablation Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Interventional Tumor Ablation Market Size by Region (2018-2023)
8.4 Asia-Pacific Interventional Tumor Ablation Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Interventional Tumor Ablation Market Size (2018-2029)
9.2 Latin America Interventional Tumor Ablation Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Interventional Tumor Ablation Market Size by Country (2018-2023)
9.4 Latin America Interventional Tumor Ablation Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Interventional Tumor Ablation Market Size (2018-2029)
10.2 Middle East & Africa Interventional Tumor Ablation Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Interventional Tumor Ablation Market Size by Country (2018-2023)
10.4 Middle East & Africa Interventional Tumor Ablation Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boston Scientific Corporation
11.1.1 Boston Scientific Corporation Company Detail
11.1.2 Boston Scientific Corporation Business Overview
11.1.3 Boston Scientific Corporation Interventional Tumor Ablation Introduction
11.1.4 Boston Scientific Corporation Revenue in Interventional Tumor Ablation Business (2018-2023)
11.1.5 Boston Scientific Corporation Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Interventional Tumor Ablation Introduction
11.2.4 Johnson & Johnson Revenue in Interventional Tumor Ablation Business (2018-2023)
11.2.5 Johnson & Johnson Recent Development
11.3 Medtronic Plc
11.3.1 Medtronic Plc Company Detail
11.3.2 Medtronic Plc Business Overview
11.3.3 Medtronic Plc Interventional Tumor Ablation Introduction
11.3.4 Medtronic Plc Revenue in Interventional Tumor Ablation Business (2018-2023)
11.3.5 Medtronic Plc Recent Development
11.4 Varian Medical Systems
11.4.1 Varian Medical Systems Company Detail
11.4.2 Varian Medical Systems Business Overview
11.4.3 Varian Medical Systems Interventional Tumor Ablation Introduction
11.4.4 Varian Medical Systems Revenue in Interventional Tumor Ablation Business (2018-2023)
11.4.5 Varian Medical Systems Recent Development
11.5 EDAP TMS S.A.
11.5.1 EDAP TMS S.A. Company Detail
11.5.2 EDAP TMS S.A. Business Overview
11.5.3 EDAP TMS S.A. Interventional Tumor Ablation Introduction
11.5.4 EDAP TMS S.A. Revenue in Interventional Tumor Ablation Business (2018-2023)
11.5.5 EDAP TMS S.A. Recent Development
11.6 AngioDynamics
11.6.1 AngioDynamics Company Detail
11.6.2 AngioDynamics Business Overview
11.6.3 AngioDynamics Interventional Tumor Ablation Introduction
11.6.4 AngioDynamics Revenue in Interventional Tumor Ablation Business (2018-2023)
11.6.5 AngioDynamics Recent Development
11.7 CASCINATION AG
11.7.1 CASCINATION AG Company Detail
11.7.2 CASCINATION AG Business Overview
11.7.3 CASCINATION AG Interventional Tumor Ablation Introduction
11.7.4 CASCINATION AG Revenue in Interventional Tumor Ablation Business (2018-2023)
11.7.5 CASCINATION AG Recent Development
11.8 Merit Medical Systems
11.8.1 Merit Medical Systems Company Detail
11.8.2 Merit Medical Systems Business Overview
11.8.3 Merit Medical Systems Interventional Tumor Ablation Introduction
11.8.4 Merit Medical Systems Revenue in Interventional Tumor Ablation Business (2018-2023)
11.8.5 Merit Medical Systems Recent Development
11.9 STARmed
11.9.1 STARmed Company Detail
11.9.2 STARmed Business Overview
11.9.3 STARmed Interventional Tumor Ablation Introduction
11.9.4 STARmed Revenue in Interventional Tumor Ablation Business (2018-2023)
11.9.5 STARmed Recent Development
11.10 Biomedical Srl
11.10.1 Biomedical Srl Company Detail
11.10.2 Biomedical Srl Business Overview
11.10.3 Biomedical Srl Interventional Tumor Ablation Introduction
11.10.4 Biomedical Srl Revenue in Interventional Tumor Ablation Business (2018-2023)
11.10.5 Biomedical Srl Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details